Lymphoma - A Therapeutic & Competitive Insight (PRWEB Jun 20, 2006)

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies”. http://www.piribo.com/publications/technology/triple_progress_analysis_lymphoma_therapeutics_protein_kinase_inhibitors_therapeutic_antibodies.html (PRWEB Aug 31, 2006)

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies”. http://www.piribo.com/publications/technology/triple_progress_analysis_lymphoma_therapeutics_protein_kinase_inhibitors_therapeutic_antibodies.html (PRWEB Aug 31, 2006)

WirelessEmporium.com Encourages Joining the Leukemia and Lymphoma Society’s Team in Training program to improve personal fitness and the health of others. (PRWEB Jun 2, 2006)

WirelessEmporium.com Encourages Joining the Leukemia and Lymphoma Society’s Team in Training program to improve personal fitness and the health of others. (PRWEB Jun 2, 2006)

NEW YORK (Reuters Health) - Using hair dye may increase the risk of a type of cancer known as lymphoma, a European study shows.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Commercial Insight: Transplantation”. http://www.piribo.com/publications/treatments/commercial_insight_transplantation.html (PRWEB Aug 20, 2006)

GreekForMe.com a Greek merchandise store sponsors Michael Galbus, cancer survivor in PF Chang's Rock-n-Roll Marathon in Phoenix Arizona. Michael was diagnosed and has survived Non-Hodgkin's lymphoma. He is running this race with Team in Training to raise awareness for the Leukemia & Lymphoma Society. (PRWeb Dec 21, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/U3F1YS1aZXRhLUluc2UtVGhpci1NYWduLVplcm8=